Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer. Large-scale metabolomic data have associated metabolic alterations with the pathogenesis and progression of renal carcinoma and have correlated mitochondrial activity with poor survival in a subset of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rupert, Christofer, Dell’ Aversana, Carmela, Mosca, Laura, Montanaro, Vittorino, Arcaniolo, Davide, De Sio, Marco, Bilancio, Antonio, Altucci, Lucia, Palinski, Wulf, Pili, Roberto, de Nigris, Filomena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214673/
https://www.ncbi.nlm.nih.gov/pubmed/37231503
http://dx.doi.org/10.1186/s13046-023-02713-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214673/
https://www.ncbi.nlm.nih.gov/pubmed/37231503
http://dx.doi.org/10.1186/s13046-023-02713-1

Ejemplares similares